Covid-19 vaccine: SII to scale-up production of Covishield

BL Internet Desk | Updated on April 21, 2021

The company welcomes the Centre's move to ramp up the vaccination drive

Following the Central Government’s decision to ramp up the Covid-19 vaccination drive in India, Pune-based Serum Institute of India said that it welcomes the move.

In a media statements, the company that is run by Adar Poonawalla, said that it for the next months, it would scale up its production to meet the rise in demands for their vaccine called Covishield.

Watch the video.

Published on April 21, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.